ClinicalTrials.gg
Sign In

Dyslipidemias clinical trials

The registry lists 1,247 studies for Dyslipidemias across more than 10 countries. 175 are recruiting or about to start. 478 of them are mainly about Dyslipidemias (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 8 narrower conditions too, such as Hypercholesterolemia: 3,416 studies, 426 open.

ClinicalTrials.gov finds 3,529 studies for Dyslipidemias. How that becomes 1,246 here

This page counts the studies the registry files under Dyslipidemias, and those it files under no condition that list Dyslipidemiasthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 3,529Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −2,098Filed under a narrower condition, counted on its own pageHypercholesterolemia 992 · Hyperlipidemias 650 · Hypertriglyceridemia 231 · Hyperlipoproteinemia Type II 152 · Homozygous Familial Hypercholesterolemia 37 · Hyperlipoproteinemias 14 · 2 more
  3. −14List Dyslipidemias as a condition, but the registry did not file them under itMost often written as “Atherogenic Dyslipidemia” (5), “Dyslipidemia Associated With Type II Diabetes Mellitus” (4), and “Diabetic Dyslipidemia” (1). The registry filed them under other conditions only, most often Diabetes Mellitus, Type 2 (6) and Insulin Resistance (5).
  4. −171Match it another way49 name it in the title, 6 in a keyword, and 116 by a synonym or other text the search reads.
  5. 1,246The count on this page47 of them list Dyslipidemias in their own words; the registry filed them under no condition.

Get an email when these change. Save the Dyslipidemias studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
818
Status unknown
118
Recruiting
111
Terminated
56
Not yet recruiting
52
Active, not recruiting
47

Phase

Phase 3
218
Phase 1
153
Phase 2
148
Phase 4
133
Early Phase 1
5

Where

United States
349
Korea, Republic of
155
Canada
84
China
72
Netherlands
60
Germany
57

Who runs them

AstraZeneca (57) · Takeda (47) · Chong Kun Dang Pharmaceutical (43) · Merck Sharp & Dohme LLC (25) · Novartis Pharmaceuticals (19) · Pfizer (16) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (15) · Yonsei University (13)

What is being tested here

Drugs under test in Dyslipidemias studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ezetimibe3118
Bempedoic acid306
Rosuvastatin21442
Pitavastatin21220
Inclisiran257
EDP167203
Metformin1717
TA-89951314
Choline fenofibrate1813
Fenofibric acid1813

Drug classes tested here Statins 5 open · PCSK9 inhibitors 2 open · Angiotensin receptor blockers (ARBs) 20 · DPP-4 inhibitors 14 · Calcium channel blockers 13

Coming up

18phase 3 studies under way
62studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 111 Dyslipidemias studies recruiting now, 55 (50%) set no upper age limit and 36 (32%) stop at 75 or younger. 11 (10%) take children under 18. 4 (4%) are for women only and 0 (0%) for men only; 28 (25%) take healthy volunteers.

Recruiting studies that take each age, of 111
AgeWomenMen
1010 (9%)9 (8%)
1856 (50%)54 (49%)
3092 (83%)89 (80%)
4096 (86%)93 (84%)
50101 (91%)98 (88%)
6595 (86%)93 (84%)
7585 (77%)84 (76%)
8564 (58%)63 (57%)

Across all 1,247 studies, recruiting or not: 46% stop at 75 or younger and 27% at 65; 9% take children; 3% are for women only and 5% for men only; 32% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Dyslipidemias studies take

Of 83 phase 1 interventional studies under Dyslipidemias, half reached primary completion within 2 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 12 mo1–10 · 83 studies2 mo1–8 · 77 studies—
Phase 213 mo7–21 · 43 studies12 mo8–18 · 35 studies—
Phase 322 mo12–45 · 62 studies22 mo12–36 · 52 studies—
Phase 429 mo22–40 · 37 studies——
Interventional, no phase16 mo8–36 · 205 studies—18 mo7–42 · 194 studies
Observational40 mo23–118 · 89 studies31 mo19–40 · 34 studies81 mo30–203 · 55 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Newly registered12

Show 7 more

Studies

Recruiting first, then most recently updated. Showing 50 of 1,247. Browse all 1,247 → or search them.